EZH2 and small cell lung carcinoma: In addition, chemotherapy resistance mechanisms associated with the frequently observed loss of Schlafen11 (SLFN11) expression could be restored by EZH2 inhibition (Gardner et al., 2017), although this was not observed in a set of SCLC PDX models (Drapkin et al., 2018).